Rossari Biotech Ltd

For the third consecutive session, Rossari Biotech Ltd has declined, culminating in a fresh 52-week low of Rs 395 on 23 Mar 2026. This marks a significant 48.5% drop from its 52-week high of Rs 767.55, underscoring persistent selling pressure amid a challenging market backdrop.

Rossari Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Rossari Biotech Ltd’s share price plunged to an all-time low of ₹400.4 on 23 March 2026, marking a significant milestone in the stock’s extended period of decline. The company’s shares have underperformed both the broader market and its sector peers, reflecting a challenging phase for the specialty chemicals firm.

For the second consecutive session, Rossari Biotech Ltd closed lower, hitting a fresh all-time low of Rs. 413.8 on 20 Mar 2026, amid continued underperformance relative to its sector and benchmark indices.

For the second consecutive session, Rossari Biotech Ltd has declined, culminating in a fresh 52-week low of Rs 414.15 on 20 Mar 2026. This marks a significant 46% drop from its 52-week high of Rs 767.55, underscoring persistent selling pressure despite a broadly positive market backdrop.

Rossari Biotech Ltd, a player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.418.3 today, marking a significant decline in its stock price amid ongoing challenges and market pressures. This fresh low reflects a continuation of the stock's downward trajectory over the past year, underscoring persistent concerns around its financial performance and valuation metrics.

Rossari Biotech Ltd, a player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.428.1 today, marking a significant decline amid a sustained downward trend over recent sessions.

Rossari Biotech Ltd, a player in the specialty chemicals sector, has recorded a new all-time low of Rs.428.1 today, marking a significant milestone in its ongoing decline. The stock’s performance continues to trail both its sector and broader market indices, reflecting a sustained period of underperformance.

Rossari Biotech Ltd, a player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.434.35, marking a significant decline in its stock price amid ongoing market pressures and company-specific performance factors.

Rossari Biotech Ltd, a player in the Specialty Chemicals sector, has reached a new all-time low of Rs.436.6, marking a significant milestone in its ongoing decline. The stock has underperformed its sector and benchmark indices consistently, reflecting a challenging period for the company and its shareholders.

Rossari Biotech Ltd, a player in the Specialty Chemicals sector, recorded a new 52-week low of Rs.446.25 on 13 Mar 2026, marking a significant decline in its stock price amid a broader market downturn and persistent underperformance relative to benchmarks.

Rossari Biotech Ltd, a player in the Specialty Chemicals sector, has recorded a new all-time low of Rs.447.8 on 13 Mar 2026, marking a significant milestone in its ongoing decline. The stock’s performance continues to lag behind key benchmarks, reflecting persistent downward pressure amid a challenging market environment.

Rossari Biotech Ltd, a player in the specialty chemicals sector, has recorded a new all-time low of Rs. 450.85 on 12 March 2026, marking a significant milestone in its ongoing downward trajectory. The stock’s performance continues to lag behind key benchmarks, reflecting persistent pressures within the market and company-specific factors.

Rossari Biotech Ltd’s stock declined sharply to a new 52-week low of Rs.450.85 on 12 Mar 2026, marking a significant drop amid broader market weakness and sector underperformance. The stock’s fall comes after a brief two-day rally and reflects ongoing pressures within the specialty chemicals sector and the wider market environment.

Rossari Biotech Ltd is rated Sell by MarketsMOJO. This rating was last updated on 08 Dec 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 12 March 2026, providing investors with the latest perspective on the company’s position.

Rossari Biotech Ltd’s shares declined to a fresh 52-week low of Rs.452 on 9 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a continuation of the stock’s underperformance relative to its sector and benchmark indices over the past year.

Rossari Biotech Ltd, a player in the Specialty Chemicals sector, has reached a new all-time low of Rs.454.4, marking a significant milestone in its ongoing decline. The stock’s recent performance reflects sustained pressure, with returns sharply lagging behind benchmark indices and sector peers.